Wall Street Wizardry
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

Wall Street Wizardry

Investing

CG1 Non-renounceable Pro-rata Entitlement Offer

by admin August 22, 2025
August 22, 2025
CG1 Non-renounceable Pro-rata Entitlement Offer

Carbonxt Group (CG1:AU) has announced CG1 non-renounceable pro-rata entitlement offer

Download the PDF here.

This post appeared first on investingnews.com

previous post
How a ship that glides like a pelican could change travel and defense
next post
Top 5 Copper Reserves by Country

Related Posts

Completion of the Acquisition of the Webbs Consol...

November 28, 2025

Fortune Bay Announces Option Agreement for the Woods...

August 5, 2025

Crypto Market Recap: US Unveils Bitcoin Reserve, Solana...

March 8, 2025

Significant Mineralisation Confirmed In Sweden

October 21, 2025

Charbone Hydrogene annonce des debentures convertibles de remplacement...

September 19, 2025

Aurum Returns High Grade Gold Intercepts at Tchaga,...

December 11, 2025

Tartisan Nickel Corp.

February 21, 2026

Mining Industry’s Exploration Spending Lagging, Will Budgets Grow...

March 19, 2025

How to Invest in Biotechnology (Updated 2024)

February 19, 2025

Sun Summit Minerals

January 19, 2026

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 26, 2025
    • 2

      Financial Agreement signed releasing $2M grant

      January 23, 2025
    • 3

      Netflix shares soar as company reports surging revenue, tops 300 million subscribers

      January 23, 2025
    • 4

      Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

      January 23, 2025
    • 5

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 6

      US security contractor will take charge of key checkpoint in Gaza as Israeli forces withdraw

      January 25, 2025
    • 7

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • Terms and Conditions
    • Privacy Policy

    Disclaimer: wallstreetwizardry.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 wallstreetwizardry.com | All Rights Reserved